Tahmasebi, A, Jamali, B, Atabaki, V, Sarker, SD, Nahar, L, Min, HJ and Lee, CW (2024) A comprehensive review of the botany, ethnopharmacology, phytochemistry and pharmacological activities of two Iranian Rydingia species (Lamiaceae). Fitoterapia, 176. ISSN 0367-326X
Text
A comprehensive review of the botany, ethnopharmacology, phytochemistry, and pharmacological activities of two Iranian Rydingia species (Lamiaceae).pdf - Accepted Version Restricted to Repository staff only until 19 May 2025. Available under License Creative Commons Attribution Non-commercial No Derivatives. Download (1MB) |
Abstract
Rydingia michauxii and R. persica, respectively, known as Kase Gol and Goldar in Persian, belong to the family Lamiaceae and they are well known herbal medicine in Iran for the treatment of various diseases, particularly diabetes. This review aims to appraise the phytochemistry, ethnopharmacology, and pharmacological activities of Rydingia species growing in Iran and assess their potential in clinical applications. Besides, it critically evaluates existing literature and looks into the perspective for further research and utilization. All available scientific literature was consulted using the database searches involving Google Scholar, PubMed, and Web of Science applying the keyword Rydingia and its Syn; Otostegia. Only the search results that are associated with the Iranian species R. michauxii and R. persica are included in this review. α-pinene, carvacrol, caryophyllene oxide, diisooctyl phthalate, dillapiole, eugenol, hexadecanoic acid, and pentacosane are the major constituents of the essential oils of the Rydingia species. Additionally, these species produce bioactive flavonoids, phenolic acids, steroids, and terpenoids. Extracts and active compounds from Rydingia species have been reported to possess various pharmacological activities including antidiabetic, anti-inflammatory, antimalarial, antimicrobial, antioxidant, cytotoxic, and lipid-lowering properties. Based on the information available to date on the Iranian Rydingia species, it will be worth subjecting these species to further developmental work involving preclinical and clinical trials.
Item Type: | Article |
---|---|
Uncontrolled Keywords: | 0607 Plant Biology; 1104 Complementary and Alternative Medicine; Medicinal & Biomolecular Chemistry |
Subjects: | Q Science > QH Natural history > QH301 Biology Q Science > QK Botany R Medicine > RS Pharmacy and materia medica |
Divisions: | Pharmacy & Biomolecular Sciences |
Publisher: | Elsevier |
SWORD Depositor: | A Symplectic |
Date Deposited: | 20 May 2024 14:46 |
Last Modified: | 03 Jun 2024 13:45 |
DOI or ID number: | 10.1016/j.fitote.2024.106026 |
URI: | https://researchonline.ljmu.ac.uk/id/eprint/23309 |
View Item |